Connection
Sarah Anderson to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Sarah Anderson has written about Diabetes Mellitus, Type 2.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.828 |
|
|
|
-
Anderson SL, Beutel TR, Trujillo JM. Oral semaglutide in type 2 diabetes. J Diabetes Complications. 2020 04; 34(4):107520.
Score: 0.235
-
Anderson SL, Trujillo JM, Anderson JE, Tanenberg RJ. Switching basal insulins in type 2 diabetes: practical recommendations for health care providers. Postgrad Med. 2018 Mar; 130(2):229-238.
Score: 0.204
-
Anderson SL, Trujillo JM, McDermott M, Saseen JJ. Determining predictors of response to exenatide in type 2 diabetes. J Am Pharm Assoc (2003). 2012 Jul-Aug; 52(4):466-71.
Score: 0.140
-
Anderson SL, Marrs JC. Dapagliflozin for the treatment of type 2 diabetes. Ann Pharmacother. 2012 Apr; 46(4):590-8.
Score: 0.137
-
Fosmire Rundgren EW, Anderson SL, Marrs JC. Response to comment "Evaluation of aspirin use for primary prevention in diabetic patients". Ann Pharmacother. 2015 Feb; 49(2):262-3.
Score: 0.042
-
Fosmire Rundgren EW, Anderson SL, Marrs JC. Evaluation of aspirin use in patients with diabetes receiving care in community health. Ann Pharmacother. 2015 Feb; 49(2):170-7.
Score: 0.041
-
Anderson SL, Trujillo JM. Association of pancreatitis with glucagon-like peptide-1 agonist use. Ann Pharmacother. 2010 May; 44(5):904-9.
Score: 0.030